Azithromycin and Auvi-q drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azithromycin (azithromycin) and Auvi-q (epinephrine). Common drug interactions include discomfort among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Azithromycin and Auvi-q. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Azithromycin?

Azithromycin has active ingredients of azithromycin. It is often used in sinusitis. eHealthMe is studying from 40,716 Azithromycin users. Check the latest studies of Azithromycin.

What is Auvi-q?

Auvi-q has active ingredients of epinephrine. eHealthMe is studying from 878 Auvi-q users. Check the latest studies of Auvi-q.

On Jul, 17, 2026

11 people who take Azithromycin and Auvi-q together, and have interactions are studied.

Azithromycin and Auvi-q drug interactions.

What are the common drug interactions of Azithromycin and Auvi-Q, by gender? *:

female:

Discomfort
Eye irritation
Injection site erythema (redness at injection site)
Injection site pruritus (severe itching at injection site)
Injection site swelling
Injection site urticaria (rash of round, red welts on the skin at injection site)
Ligament sprain (ligament stretched)
Rash
Sleep disorder
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)

male:

Asthma
Drug ineffective
Ear infection
Cystic fibrosis (disease of the secretary glands)
Influenza
Nasopharyngitis (inflammation of the nasopharynx)
Productive cough

What are the common drug interactions of Azithromycin and Auvi-Q, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Discomfort
Eye irritation
Influenza
Nasopharyngitis (inflammation of the nasopharynx)
Productive cough
Rash
Sleep disorder
Asthma
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Drug ineffective

20-29:

n/a

30-39:

Injection site erythema (redness at injection site)
Injection site pruritus (severe itching at injection site)
Injection site swelling
Injection site urticaria (rash of round, red welts on the skin at injection site)

40-49:

Decreased immune responsiveness

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 4 people, 36.36%
Cystic Fibrosis (disease of the secretary glands): 3 people, 27.27%
Asthma: 2 people, 18.18%
Neurodermatitis (a skin disorder characterized by long lasting itching and scratching): 1 person, 9.09%
Nasal Polyps (masses that develop in the lining of the nose): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Azithromycin and Auvi-q?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously